Life Sciences organizations face growing pressure to generate real-world evidence (RWE) faster and at greater scale-for internal decision-making, publication, and external stakeholders, including regulators and payers.Speed is now…

Life Sciences is at an inflection point. Real-world data (RWD) and AI have progressed from pilot programs and proof-of-concept experimentation to core components of clinical development and evidence…

I. The Persistent Execution Gap in RWE Generation in Clinical Development We have previously articulated the case for systematic, integrated RWE generation beginning early in drug development -…

Life sciences organizations have long struggled with fragmented, time-intensive processes for discovering, assessing, and purchasing real-world data (RWD). These bottlenecks delay evidence generation, slow clinical and commercial decision-making,…

For life sciences organizations, medical record retrieval unlocks the “last mile” of real-world data (RWD) – providing access to complete, patient-level records that fill gaps left by traditional…

As digital health outpaces regulation, tokenization offers a scalable path to privacy and trust, enabling advancements that support regulatory, patient, and consumer priorities.

Datavant Life Sciences’ annual RWD Connect industry event brings together leaders from across our 350+ real-world data partners, including many of the world’s top 20 pharmaceutical companies, to…

As the healthcare data landscape continues to evolve and transform, the ability to discover and evaluate real-world data (RWD) with speed and precision is a critical advantage. For…